NASDAQ:MYLMylan Stock Price, Forecast & News

Mylan's stock was trading at $14.47 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MYL shares have increased by 11.9% and is now trading at $16.19.
View which stocks have been most impacted by COVID-19.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mylan in the last year. There are currently 5 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Mylan.

Mylan is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Mylan.

Mylan NV (NASDAQ:MYL) issued its earnings results on Thursday, August, 6th. The company reported $1.11 EPS for the quarter, beating the consensus estimate of $0.95 by $0.16. The firm earned $2.73 billion during the quarter, compared to analysts' expectations of $2.74 billion. Mylan had a return on equity of 20.43% and a net margin of 2.35%. The company's quarterly revenue was down 4.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.03 earnings per share.
View Mylan's earnings history.

Mylan updated its FY 2020 Pre-Market earnings guidance on Thursday, August, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $11.5-12 billion, compared to the consensus revenue estimate of $11.62 billion.

8 equities research analysts have issued 12 month price objectives for Mylan's shares. Their forecasts range from $17.00 to $27.00. On average, they expect Mylan's share price to reach $20.67 in the next twelve months. This suggests a possible upside of 27.7% from the stock's current price.
View analysts' price targets for Mylan.

Press coverage about MYL stock has trended neutral recently, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Mylan earned a media sentiment score of 0.2 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days.
View the latest news about Mylan.

Mylan saw a increase in short interest in May. As of May 15th, there was short interest totaling 27,660,000 shares, an increase of 20.5% from the April 30th total of 22,960,000 shares. Based on an average daily trading volume, of 7,886,400 shares, the days-to-cover ratio is presently 3.5 days. Currently, 5.4% of the shares of the company are sold short.
View Mylan's Short Interest.

Some companies that are related to Mylan include Johnson & Johnson (JNJ), Pfizer (PFE), Merck & Co., Inc. (MRK), AbbVie (ABBV), Eli Lilly And Co (LLY), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Royalty Pharma (RPRX), Horizon Therapeutics (HZNP), Perrigo (PRGO), Jazz Pharmaceuticals (JAZZ), Nektar Therapeutics (NKTR), Pacira Biosciences (PCRX), Corcept Therapeutics (CORT) and Zogenix (ZGNX).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Mylan investors own include Gilead Sciences (GILD), Alibaba Group (BABA), Pfizer (PFE), Teva Pharmaceutical Industries (TEVA), Micron Technology (MU), NVIDIA (NVDA), Cisco Systems (CSCO), Intel (INTC), AbbVie (ABBV) and Starbucks (SBUX).

Mylan trades on the NASDAQ under the ticker symbol "MYL."

Mylan's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (11.09%), Pzena Investment Management LLC (3.24%), FIL Ltd (2.94%), Paulson & CO. Inc. (2.22%), Bank of New York Mellon Corp (0.95%) and Senator Investment Group LP (0.68%). Company insiders that own Mylan stock include Goulds Bruce, Melina E Higgins, Paul Campbell, Richard A Mark, Robert J Coury and Sjoerd S Vollebregt.
View institutional ownership trends for Mylan.

MYL stock was sold by a variety of institutional investors in the last quarter, including Pzena Investment Management LLC, Vanguard Group Inc., First Trust Advisors LP, Glenmede Trust Co. NA, State of Wisconsin Investment Board, Paulson & CO. Inc., State of Tennessee Treasury Department, and Baird Financial Group Inc..
View insider buying and selling activity for Mylan.

MYL stock was bought by a variety of institutional investors in the last quarter, including Senator Investment Group LP, FIL Ltd, US Bancorp DE, AJO LP, Point72 Asset Management L.P., Russell Investments Group Ltd., State of Alaska Department of Revenue, and Marshall Wace LLP. Company insiders that have bought Mylan stock in the last two years include Melina E Higgins, Richard A Mark, Robert J Coury, and Sjoerd S Vollebregt.
View insider buying and selling activity for Mylan.

Shares of MYL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of MYL stock can currently be purchased for approximately $16.19.

Mylan has a market capitalization of $8.37 billion and generates $11.50 billion in revenue each year. The company earns $16.80 million in net income (profit) each year or $4.42 on an earnings per share basis. Mylan employs 35,000 workers across the globe.

The official website for Mylan is www.mylan.com.

Mylan's mailing address is 1000 MYLAN BOULEVARD, CANONSBURG PA, 15317. The company can be reached via phone at 724-514-1800 or via email at [email protected]